Effects of Acute Elevation of Circulating Fatty Acids on Skeletal Muscle Lipid Accumulation and Metabolism in Healthy Lean Young Men
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Change in IntraMyoCellularLipid (IMCL)content
Study Overview
Brief Summary
There is increasing evidence that skeletal muscle lipid content (IntraMyoCellular Lipid, IMCL) markedly increases the risk of metabolic complications, including insulin resistance and cardiovascular events. The investigator hypothesizes that skeletal muscle is passively taking up FFAs when the availability is high, thereby leading to an increased storage. To test this hypothesis, the investigator wants to manipulate FFA levels, by means of exercise, and monitor intramuscular lipid content.
Therefore the objective is to examine the effect of an exercise-induced elevation of FFA on skeletal muscle lipid content in healthy lean men. To this end, skeletal muscle lipid content will be investigated at baseline and after an exercise protocol and again after a four-hour recovery period from exercise, once in a condition with high FFA concentration, once with low FFA concentration. To achieve high- versus low FFA concentrations, an exercise protocol was chosen and participants had to perform this protocol once with a glucose supplementation and once without.
Skeletal muscle lipid content will be determined before, directly after exercise and 4 h post exercise (from muscle biopsies) with or without glucose supplementation.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 30 Years (Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Age 18-30 years
- •Lean, BMI 18-25 kg/m2
- •Stable dietary habits
- •No medication use
Exclusion Criteria
- •Female sex
- •Engagement in programmed exercise > 2 hours total per week
- •Cardiac problems, such as angina pectoris, cardiac infarction and arrhythmias
- •First degree relatives with type 2 diabetes mellitus
- •Any medical condition requiring treatment and/or medication use
- •Unstable body weight (weight gain or loss > 3 kg in the past three months)
- •Participation in other biomedical study within 1 month prior to the screening visit
- •Subjetcs, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed, cannot participate in the study
Arms & Interventions
Exercise & Glucose
2 hour exercise while getting glucose-supplementation
Intervention: Exercise (Other)
Exercise & Fasted
2 hour exercise while staying fasted
Intervention: Exercise (Other)
Exercise & Fasted
2 hour exercise while staying fasted
Intervention: Fasted (Other)
Exercise & Glucose
2 hour exercise while getting glucose-supplementation
Intervention: Glucose (Other)
Outcomes
Primary Outcomes
Change in IntraMyoCellularLipid (IMCL)content
Time Frame: Baseline, directly postexercise and 4 hours post-exercise
A muscle biopsy will be withdrawn before, after 2 hours of exercise and again 4 hours post-exercise for later analysis of IMCL.
Secondary Outcomes
- Change in substrate metabolism(Measured several time points during the test day)
Investigators
Lena Bilet
PhD student
Maastricht University Medical Center